Acorda Therapeutics, Inc. (NGSX) Today, NGSX has shed (-6.67%) down -0.0005 at $.0070 with 29,206 shares in play thus far (ref. google finance Delayed: 10:44AM EDT July 17, 2013), but don’t let this get you down. Acorda Therapeutics, Inc. previously reported it has acquired two neuropathic pain management assets from NeurogesX, Inc. (OTCBB: NGSX). Qutenza® [...]
↧
Acorda Therapeutics Announced Acquisition of 2 Neuropathic Pain Assets (OTCMKTS:NGSX, OTCMKTS:CRWE)
↧